期刊
JOURNAL OF INFECTIOUS DISEASES
卷 195, 期 12, 页码 1762-1764出版社
UNIV CHICAGO PRESS
DOI: 10.1086/518250
关键词
-
资金
- Intramural NIH HHS Funding Source: Medline
- NCRR NIH HHS [M01 RR-00037] Funding Source: Medline
- NIAID NIH HHS [AI57005, AI41535] Funding Source: Medline
The persistence of latently infected resting CD4(+) T cells has been clearly demonstrated in human immunodeficiency virus (HIV)-infected individuals receiving effective antiviral therapy. However, estimates of the half-life of this viral reservoir have been quite divergent. We demonstrate clear evidence for decay of this HIV reservoir in patients who initiated antiviral therapy early in infection. The half-life of this latent viral reservoir was estimated to be 4.6 months. It is projected that it will take up to 7.7 years of continuous therapy to completely eliminate latently infected resting CD4(+) T cells in infected individuals who initiate antiviral therapy early in HIV infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据